Login Register Cart 0
Research Article

Effects of Calamintha incana (Sm.) Helder Ethanolic Extract on the mRNA Expression of Drug-metabolizing cyp450s in the Mouse Livers

Author(s): Arwa R. Althaher*, Yazun Jarrar*, Mahmood Ayad Al-Ibadah, Ruba Balasmeh, Qais Jarrar and Dina Abulebdah

Volume 13, Issue 1, 2024

Published on: 23 January, 2024

Page: [63 - 70] Pages: 8

DOI: 10.2174/0122115366268781231205103752

Price: $65

Abstract

Background: Alteration in the expression and activity of drug-metabolizing enzymes (DMEs) can alter the pharmacokinetics and hence the response of the drug. Some chemicals found in herbs and fruits affect the expression of DMEs. Calamintha incana is commonly used in Middle Eastern Arabic countries. There is no report regarding the influence of Calamintha incana on the hepatic expression of DMEs.

Aims: The current investigation aimed to investigate the effect of Calamintha incana consumption on the mRNA expression of major hepatic drug-metabolizing cytochrome (cyp) P450 genes in mice.

Methods: The chemical composition of the ethanoic extract was analyzed using liquid chromatography/ mass spectrometry. Then, 21 BALB/c mice were used for the in vivo experiment. The mice were divided into three groups, each consisting of seven mice. The first group (low-dose group) was treated with 41.6 mg/kg of Calamintha incana extract and the second group was administered the high-dose (125 mg/kg) of the extract for one month. The mice in the third “control” group administrated the vehicle 20% polyethylene glycol 200. Then, the expression of cyp3a11, cyp2c29, cyp2d9, and cyp1a1 was analyzed using the real-time polymerase chain reaction. The relative liver weights of the mice and the hepatic pathohistological alterations were assessed.

Results: The ethanolic extract of Calamintha incana contained 27 phytochemical compounds. The most abundant compounds were linolenic acid, myristic acid, and p-cymene. It was found that the low dose of Calamintha incana extract upregulated significantly (P < 0.05) the expression of cyp3a11 by more than ten folds in the liver of treated mice. Furthermore, the histological analysis showed that low- and high-dose administration of the C. incana did not cause pathological alterations.

Conclusion: It can be concluded from these findings that consumption of low doses of Calamintha incana upregulated the mRNA expression of mouse cyp3a11 without causing histopathological alterations in the livers. Further studies are needed to determine the influence of Calamintha incana on the pharmacokinetics and response of drugs metabolized by cyp3a11.

Keywords: Calamintha incana, cyp3a11, drug-metabolizing enzymes, liver, mRNA expression, cyp450s, mouse livers.

« Previous Next »
Graphical Abstract

[1]
Bittner Fialová S, Rendeková K, Mučaji P, Nagy M, Slobodníková L. Antibacterial activity of medicinal plants and their constituents in the context of skin and wound infections, considering european legislation and folk medicine-a review. Int J Mol Sci 2021; 22(19): 10746.
[http://dx.doi.org/10.3390/ijms221910746] [PMID: 34639087]
[2]
Aleebrahim-Dehkordy E, Nasri H, Baradaran A, et al. Medicinal plants, effective plant compounds (Compositions) and their effects on stomach cancer. Int J Prev Med 2017; 8: 96.
[http://dx.doi.org/10.4103/ijpvm.IJPVM_4_17] [PMID: 29184647]
[3]
Riaz M, Khalid R, Afzal M, Anjum F, Fatima H, Zia S. Phytobioactive compounds as therapeutic agents for human diseases: A review. Food Sci Nutr 2023; 11(6): 2500-29.
[http://dx.doi.org/10.1002/fsn3.3308]
[4]
Kaushik B, Sharma J, Yadav K, Kumar P, Shourie A. others. Phytochemical properties and pharmacological role of plants: Secondary metabolites. Biosci Biotechnol Res Asia 2021; 18(1): 23-35.
[http://dx.doi.org/10.13005/bbra/2894]
[5]
Roychoudhury A, Bhowmik R. Health benefits of plant-derived bioactive secondary metabolites as dietary constituents. SF J Clin Pharm Res 2020; 2: 1002.
[6]
Balasmeh R, Jarrar Y, Al-Sheikh I, et al. Effects of fasting and phoenix dactylifera on the expression of major drug- metabolizing enzymes in the mouse livers. Curr Drug Metab 2022; 23(8): 666-76.
[http://dx.doi.org/10.2174/1389200223666220820105330] [PMID: 35993475]
[7]
Al-Dosari MS, Parvez MK. Novel plant inducers of PXR-dependent cytochrome P450 3A4 expression in HepG2 cells. Saudi Pharm J 2018; 26(8): 1069-72.
[http://dx.doi.org/10.1016/j.jsps.2018.05.016] [PMID: 30532626]
[8]
Zhao M, Ma J, Li M, et al. Cytochrome P450 enzymes and drug metabolism in humans. Int J Mol Sci 2021; 22(23): 12808.
[http://dx.doi.org/10.3390/ijms222312808] [PMID: 34884615]
[9]
Bibi Z. Role of cytochrome P450 in drug interactions. Nutr Metab 2008; 5(1): 27.
[http://dx.doi.org/10.1186/1743-7075-5-27] [PMID: 18928560]
[10]
Palatini P, De Martin S. Pharmacokinetic drug interactions in liver disease: An update. World J Gastroenterol 2016; 22(3): 1260-78.
[http://dx.doi.org/10.3748/wjg.v22.i3.1260] [PMID: 26811663]
[11]
Chen J, Raymond K. Roles of rifampicin in drug-drug interactions: underlying molecular mechanisms involving the nuclear pregnane X receptor. Ann Clin Microbiol Antimicrob 2006; 5(1): 3.
[http://dx.doi.org/10.1186/1476-0711-5-3] [PMID: 16480505]
[12]
Božović M, Ragno R. Calamintha nepeta (L.) Savi and its main essential oil constituent pulegone: Biological activities and chemistry. Molecules 2017; 22(2): 290.
[http://dx.doi.org/10.3390/molecules22020290] [PMID: 28216606]
[13]
Althaher AR, Oran SA, Bustanji YK. Chemical composition, in vitro evaluation of antioxidant properties and cytotoxic activity of the essential oil from calamintha incana (Sm.) Helder (Lamiaceae). TJNPR 2021; 5(8): 1333-9.
[http://dx.doi.org/10.26538/tjnpr/v5i8.2]
[14]
Mimica-Dukić N, Couladis M, Tzakou O, Jančić R, Slavkovska V. Essential Oil of Calamintha sylvatica Bromf. and Calamintha vardarensis Šilic. J Essent Oil Res 2004; 16(3): 219-22.
[http://dx.doi.org/10.1080/10412905.2004.9698702]
[15]
Popović-Djordjević J, Cengiz M, Ozer MS, Sarikurkcu C. Calamintha incana: Essential oil composition and biological activity. Ind Crops Prod 2019; 128: 162-6.
[http://dx.doi.org/10.1016/j.indcrop.2018.11.003]
[16]
Althaher AR, Mastinu A. Calamintha incana (Sm.) helder: A new phytoextract with in vitro antioxidant and antidiabetic action. Appl Sci 2023; 13(6): 3966.
[http://dx.doi.org/10.3390/app13063966]
[17]
Dobravalskytė D, Venskutonis PR, Talou T. Antioxidant properties and essential oil composition of Calamintha grandiflora L. Food Chem 2012; 135(3): 1539-46.
[http://dx.doi.org/10.1016/j.foodchem.2012.05.094] [PMID: 22953891]
[18]
Hidalgo PJ, Libera JL, Santos JA, et al. Essential oils in Calamintha sylvatica Bromf. ssp. ascendens (Jordan) PW Ball: Wild and cultivated productions and antifungal activity. J Essent Oil Res 2002; 14(1): 68-71.
[http://dx.doi.org/10.1080/10412905.2002.9699768]
[19]
Oran SA, Althaher AR, Al Shhab MA. Chemical composition, in vitro assessment of antioxidant properties and cytotoxicity activity of ethanolic and aqueous extracts of Ajuga orientalis L. (Lamiaceae). J Pharm Pharmacogn Res 2022; 10(3): 486-95.
[http://dx.doi.org/10.56499/jppres22.1344_10.3.486]
[20]
Jarrar YB, Jarrar Q, abed A, Abu-Shalhoob M. Effects of nonsteroidal anti-inflammatory drugs on the expression of arachidonic acid-metabolizing Cyp450 genes in mouse hearts, kidneys and livers. Prostaglandins Other Lipid Mediat 2019; 141: 14-21.
[http://dx.doi.org/10.1016/j.prostaglandins.2019.02.003] [PMID: 30763676]
[21]
Jarrar Y, Al-Essa L, Kilani A, Hasan M, Al-Qerem W. Alterations in the gene expression of drug and arachidonic acid-metabolizing Cyp450 in the livers of controlled and uncontrolled insulin-dependent diabetic mice. Diabetes Metab Syndr Obes 2018; 11: 483-92.
[http://dx.doi.org/10.2147/DMSO.S172664] [PMID: 30288071]
[22]
Wilfinger WW, Mackey K, Chomczynski P. Effect of pH and ionic strength on the spectrophotometric assessment of nucleic acid purity. Biotechniques 1997; 22(3): 474-481, 478-481.
[http://dx.doi.org/10.2144/97223st01] [PMID: 9067025]
[23]
Hart SN, Cui Y, Klaassen CD, Zhong X. Three patterns of cytochrome P450 gene expression during liver maturation in mice. Drug Metab Dispos 2009; 37(1): 116-21.
[http://dx.doi.org/10.1124/dmd.108.023812] [PMID: 18845660]
[24]
Pokreisz P, Fleming I, Kiss L, et al. Cytochrome P450 epoxygenase gene function in hypoxic pulmonary vasoconstriction and pulmonary vascular remodeling. Hypertension 2006; 47(4): 762-70.
[http://dx.doi.org/10.1161/01.HYP.0000208299.62535.58] [PMID: 16505204]
[25]
Abdelrahim D, Faris ME, Hassanein M, et al. Impact of ramadan diurnal intermittent fasting on hypoglycemic events in patients with type 2 diabetes: A systematic review of randomized controlled trials and observational studies. Front Endocrinol 2021; 12: 624423.
[http://dx.doi.org/10.3389/fendo.2021.624423] [PMID: 33763029]
[26]
Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2−ΔΔCT method. Methods 2001; 25(4): 402-8.
[27]
Sofowora A, Ogunbodede E, Onayade A. The role and place of medicinal plants in the strategies for disease prevention. Afr J Tradit Complement Altern Med 2013; 10(5): 210-29.
[http://dx.doi.org/10.4314/ajtcam.v10i5.2] [PMID: 24311829]
[28]
Katiyar C, Kanjilal S, Gupta A, Katiyar S. Drug discovery from plant sources: An integrated approach. Ayu 2012; 33(1): 10-9.
[http://dx.doi.org/10.4103/0974-8520.100295] [PMID: 23049178]
[29]
Abdulraheem Al-Kafaween M, Al-Jamal HA, Mohd Hilmi AB, Elsahoryi NA, Jaffar N, Khairi Zahri M. Antibacterial properties of selected Malaysian Tualang honey against Pseudomonas aeruginosa and Streptococcus pyogenes. Iran J Microbiol 2020; 12(6): 565-76.
[http://dx.doi.org/10.18502/ijm.v12i6.5031] [PMID: 33613911]
[30]
Zhou S, Chan E, Li X, Huang M. Clinical outcomes and management of mechanism-based inhibition of cytochrome P450 3A4. Ther Clin Risk Manag 2005; 1(1): 3-13.
[http://dx.doi.org/10.2147/tcrm.1.1.3.53600] [PMID: 18360537]
[31]
Yang LQ, Li SJ, Cao YF, et al. Different alterations of cytochrome P450 3A4 isoform and its gene expression in livers of patients with chronic liver diseases. World J Gastroenterol 2003; 9(2): 359-63.
[http://dx.doi.org/10.3748/wjg.v9.i2.359] [PMID: 12532467]
[32]
Kurzawski M, Szeląg-Pieniek S, Łapczuk-Romańska J, Wrzesiński M, Oswald S, Droździk M. The reference liver-CYP450 and UGT enzymes in healthy donor and metastatic livers: the impact of genotype. Pharmacol Rep 2022; 74(1): 204-15.
[http://dx.doi.org/10.1007/s43440-021-00337-w] [PMID: 34741761]
[33]
Jarrar Y, Al-Doaiss A, Alfaifi M, Shati A, Al-Kahtani M, Jarrar B. The influence of five metallic nanoparticles on the expression of major drug-metabolizing enzyme genes with correlation of inflammation in mouse livers. Environ Toxicol Pharmacol 2020; 80: 103449.
[http://dx.doi.org/10.1016/j.etap.2020.103449] [PMID: 32593632]
[34]
Almansour MI, Jarrar YB, Jarrar BM. In vivo investigation on the chronic hepatotoxicity induced by sertraline. Environ Toxicol Pharmacol 2018; 61: 107-15.
[http://dx.doi.org/10.1016/j.etap.2018.05.021] [PMID: 29883902]
[35]
Chang TKH. Activation of pregnane X receptor (PXR) and constitutive androstane receptor (CAR) by herbal medicines. AAPS J 2009; 11(3): 590-601.
[http://dx.doi.org/10.1208/s12248-009-9135-y] [PMID: 19688601]
[36]
Satsu H, Hiura Y, Mochizuki K, Hamada M, Shimizu M. Activation of pregnane X receptor and induction of MDR1 by dietary phytochemicals. J Agric Food Chem 2008; 56(13): 5366-73.
[http://dx.doi.org/10.1021/jf073350e] [PMID: 18540626]
[37]
Ronis MJJ, Pedersen KB, Watt J. Adverse effects of nutraceuticals and dietary supplements. Annu Rev Pharmacol Toxicol 2018; 58(1): 583-601.
[http://dx.doi.org/10.1146/annurev-pharmtox-010617-052844] [PMID: 28992429]
[38]
Altemimi A, Lakhssassi N, Baharlouei A, Watson D, Lightfoot D. Phytochemicals: Extraction, isolation, and identification of bioactive compounds from plant extracts. Plants 2017; 6(4): 42.
[http://dx.doi.org/10.3390/plants6040042] [PMID: 28937585]
[39]
Thomas HJD, Myers-Smith IH, Bjorkman AD, et al. Traditional plant functional groups explain variation in economic but not size‐related traits across the tundra biome. Glob Ecol Biogeogr 2019; 28(2): 78-95.
[http://dx.doi.org/10.1111/geb.12783] [PMID: 31007605]

Rights & Permissions Print Cite
Article Metrics
15
1
© 2024 Bentham Science Publishers | Privacy Policy